ERBB2 and cancer: Furthermore, a comprehensive multi-omic analysis of malignant gastric cancers revealed genomic amplifications of established cancer driver genes such as EGFR, ERBB2, MET, FGFR2, and CD44 in gastric cancer with peritoneal metastasis [10].